In addition, bulk H3 acetylation is higher in cells expressing PolyQ-expanded Ataxin-3 Selleckchem Talazoparib [47]. This intimate interplay between Ataxin-3, transcription factors and chromatin modifiers, along with the ability of Ataxin-3 to deubiquitinate histones, provides ample opportunity for misregulation of chromatin modifications in SCA3. SCA6 is caused by polyglutamine expansion of the bicistronic calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (CACNA1A) gene, which encodes two protein products — the α1A voltage-dependent calcium

channel subunit and the α1ACT transcription factor [52••]. Full-length CACNA1A mRNA produces the α1A ion channel subunit. The α1ACT transcription factor is produced from a cryptic internal

ribosomal entry site (IRES) in the 3′ end of the transcript [52••]. Polyglutamine expansion occurs in both gene products. This expansion does not perturb calcium channel gating in knock-in studies Sirolimus chemical structure [53]. However, expression of the expanded α1ACT alone is sufficient to cause the SCA6 phenotype [54•, 55, 56 and 57]. The α1ACT protein normally coordinates expression of many genes involved in neural and Purkinje cell development. PolyQ expanded α1ACT lacks transcription factor activity yet forms intra-nuclear inclusions that co-localize with the CREB transcription factor [52•• and 58]. It is unclear whether the disease phenotype results from the lack of expression of normal α1ACT target genes or, perhaps, perturbed expression of CREB target genes. SCA7 is the most prevalent SCA disease in Scandinavian populations and is caused by expansion of the ATXN7 gene, which encodes the Ataxin-7 protein. Ataxin-7 is a subunit of the chromatin modifying Spt-Ada-Gcn5-Acetyltransferase (SAGA) complex. This highly conserved, multi-protein

complex is comprised of approximately 20 subunits and is an essential transcriptional coactivator that regulates a large number of genes [ 59••]. The complex bears two histone-modifying activities: the Gcn5/KAT2 acetyltransferase and the ubiquitin specific PtdIns(3,4)P2 protease 22 (USP22) deubiquitinase. SAGA acetylates H3K9 and H3K14, as well as other residues in histone H3 and the linker histone H1. USP22 deubiquitinates histone H2Bub and H2Aub, which are important marks for transcription activation and elongation [ 60 and 61]. Within the SAGA complex, Ataxin-7 tethers the deubiquitinase and histone acetyltransferase (HAT) modules to each other. Crystal structures of the Saccharomyces cerevisiae deubiquitinase module have shown that the amino terminus of Ataxin-7 is embedded within the module [ 62•• and 63••]. Polyglutamine expansion occurs within the amino terminus, and the repeat length can be very large ( Table 1) [ 64]. H3K9 acetylation is decreased upon polyglutamine expansion of Ataxin-7 [ 65, 66 and 67••], indicating that the expanded protein impairs the GCN5 activity within the SAGA HAT module.